[{"id":"119fae40-6e62-4861-a954-abcec9f4b889","acronym":"","url":"https://clinicaltrials.gov/study/NCT04864379","created_at":"2021-04-28T12:52:57.027Z","updated_at":"2024-07-02T16:36:31.054Z","phase":"Phase 1","brief_title":"Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors","source_id_and_acronym":"NCT04864379","lead_sponsor":"Sir Run Run Shaw Hospital","biomarkers":" CD8 • IFNG • CD4","pipe":"","alterations":" ","tags":["CD8 • IFNG • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e iNeo-Vac-P01"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 09/03/2020","start_date":" 09/03/2020","primary_txt":" Primary completion: 08/03/2025","primary_completion_date":" 08/03/2025","study_txt":" Completion: 08/03/2025","study_completion_date":" 08/03/2025","last_update_posted":"2021-04-28"}]